Abstract
The names of drugs are often formed by combining syllables taken from chemical sources so as to produce chemical-sounding names which, however, lack the meaning they would convey in a systematic context. Thus aza, prop, and one are all well known syllables combined in azapropazone to produce what is really a nonsense-word.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fenner, H and Mixich, G (1973). NMR studies of the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation. Arzneim-Forsch, 23, 667–9
Sugiyama, H, Okazaki, T and Adachi, A (1966). Empirical studies on in vivo fate of azapropazone. Presented at 13th Congress of Japanese Rheumatism Society, May 16, 1966.
Singh, SP, Parmar, SS, Stenberg, SI and Farnum, SA (1978). Carbon-13 nuclear magnetic resonance spectra of anti-inflammatory drugs: Phenylbutazone, oxyphenbutazone, and indomethacin. J Heterocycl Chem, 15, 13–16
Mixich, G (1968). The chemical behaviour of the anti-phlogistic agent azapropazone (Mi 85). Helv Chim Acta, 51, 532–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Dean, F.M. (1989). The chemical classification of azapropazone. In: Rainsford, K.D. (eds) Azapropazone. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0713-3_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-0713-3_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6806-2
Online ISBN: 978-94-009-0713-3
eBook Packages: Springer Book Archive